Novel bioreductive mitosene and mitosane analogues of mitomycin C. 1987

W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
Laboratory of Organic Chemistry, Twente University of Technology, AE Enschede, The Netherlands.

Mitosenes of both the pyrrolo- and pyrido[1,2-a]indole type have been prepared via a modified Madelung reaction of benzeneacetonitriles ortho-substituted with gamma- and delta-lactam moieties, respectively, followed by modification of the resulting heterotricyclic compounds. Some in vitro anti-tumour activity data of these novel compounds are rearrangement of 2-(1-pyrrolidinyl)-3-vinylquinone derivatives to 5,8-dioxo-1H-pyrrolo[1,2-a]indoles.

UI MeSH Term Description Entries
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
January 1994, Oncology research,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
June 2010, The Journal of biological chemistry,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
September 1992, Biochemistry,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
February 1997, Chemistry & biology,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
August 2014, Angewandte Chemie (International ed. in English),
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
November 1989, British journal of cancer,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
June 1997, Hiroshima journal of medical sciences,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
July 1991, Journal of medicinal chemistry,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
January 1989, Anticancer research,
W Verboom, and D N Reinhoudt, and B H Lammerink, and E O Orlemans, and F C van Veggel, and P Lelieveld
June 1993, Cancer metastasis reviews,
Copied contents to your clipboard!